Skip to main content

Advertisement

Figure 2 | Diabetology & Metabolic Syndrome

Figure 2

From: Caloric restriction or telmisartan control dyslipidemia and nephropathy in obese diabetic Zücker rats

Figure 2

Final values of plasma APOA1 and APOA1 hepatic mRNA. Differences between non-diabetic and diabetic obese rats at the end of experimental interventions. Data are shown as mean ± SD. Statistically significant differences *p < 0.05 vs Zücker ¶p < 0.05 vs ZDFV. Fatty-diabetic rats showed higher APOA1 plasma concentration and hepatic mRNA expression than fatty-diabetic rats that were on low-calorie diet (ZDFD) or telmisartan treatment (ZDFT).

Back to article page